T cell receptor T cell therapy

T cell receptor T cell therapy is a type of cancer treatment that uses a patient's own immune system to fight the disease. This therapy involves modifying the patient's T cells to express a specific T cell receptor (TCR) that can recognize and kill cancer cells.

Overview

T cell receptor T cell therapy is a form of adoptive cell transfer (ACT) therapy. In this treatment, T cells are taken from a patient's blood. Then, in a lab, the gene for a specific TCR is introduced into the T cells. This receptor allows the T cells to recognize cancer cells. The modified T cells are then multiplied in the lab and infused back into the patient.

Mechanism of action

The TCRs on the surface of T cells are responsible for recognizing and binding to specific antigens on the surface of cancer cells. Once the TCR binds to the antigen, it triggers the T cell to kill the cancer cell. In T cell receptor T cell therapy, the TCRs are engineered to recognize specific antigens on the patient's cancer cells.

Clinical use

T cell receptor T cell therapy has been used to treat several types of cancer, including melanoma, lung cancer, and leukemia. The therapy is still in the experimental stages, and more research is needed to determine its long-term effectiveness and safety.

See also

• Cancer immunotherapy
• Chimeric antigen receptor T cell
• Adoptive cell transfer

References

T cell receptor T cell therapy Resources
Latest articles Most recent articles Ongoing trials	Wikipedia